RU2114845C1 - Производные имидазопиридина или их фармацевтически приемлемые соли, способ их получения и фармацевтическая композиция, проявляющая антагонистическую активность в отношении гистамина (h1) - Google Patents

Производные имидазопиридина или их фармацевтически приемлемые соли, способ их получения и фармацевтическая композиция, проявляющая антагонистическую активность в отношении гистамина (h1) Download PDF

Info

Publication number
RU2114845C1
RU2114845C1 RU93054165A RU93054165A RU2114845C1 RU 2114845 C1 RU2114845 C1 RU 2114845C1 RU 93054165 A RU93054165 A RU 93054165A RU 93054165 A RU93054165 A RU 93054165A RU 2114845 C1 RU2114845 C1 RU 2114845C1
Authority
RU
Russia
Prior art keywords
pyrid
compound
formula
pharmaceutically acceptable
piperidine
Prior art date
Application number
RU93054165A
Other languages
English (en)
Russian (ru)
Other versions
RU93054165A (ru
Inventor
Алкер Дэвид
Джон Басс Роберт
Купер Келвин
Original Assignee
Пфайзер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Инк. filed Critical Пфайзер Инк.
Publication of RU93054165A publication Critical patent/RU93054165A/ru
Application granted granted Critical
Publication of RU2114845C1 publication Critical patent/RU2114845C1/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Prostheses (AREA)
RU93054165A 1991-02-13 1992-01-24 Производные имидазопиридина или их фармацевтически приемлемые соли, способ их получения и фармацевтическая композиция, проявляющая антагонистическую активность в отношении гистамина (h1) RU2114845C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9102997.5 1991-02-13
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Publications (2)

Publication Number Publication Date
RU93054165A RU93054165A (ru) 1996-09-10
RU2114845C1 true RU2114845C1 (ru) 1998-07-10

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93054165A RU2114845C1 (ru) 1991-02-13 1992-01-24 Производные имидазопиридина или их фармацевтически приемлемые соли, способ их получения и фармацевтическая композиция, проявляющая антагонистическую активность в отношении гистамина (h1)

Country Status (29)

Country Link
US (1) US5358953A (enExample)
EP (1) EP0572425B1 (enExample)
JP (1) JP2506541B2 (enExample)
KR (1) KR970005302B1 (enExample)
CN (1) CN1040326C (enExample)
AT (1) ATE109482T1 (enExample)
AU (1) AU650322B2 (enExample)
BR (1) BR9205615A (enExample)
CA (1) CA2099381C (enExample)
CZ (1) CZ280504B6 (enExample)
DE (1) DE69200304T2 (enExample)
DK (1) DK0572425T3 (enExample)
EG (1) EG20085A (enExample)
ES (1) ES2059212T3 (enExample)
FI (1) FI933531A7 (enExample)
GB (1) GB9102997D0 (enExample)
HU (2) HUT65947A (enExample)
IE (1) IE65125B1 (enExample)
IL (1) IL100887A (enExample)
MX (1) MX9200589A (enExample)
MY (1) MY108437A (enExample)
NO (1) NO300592B1 (enExample)
NZ (1) NZ241597A (enExample)
PL (1) PL169304B1 (enExample)
RU (1) RU2114845C1 (enExample)
TW (1) TW227000B (enExample)
WO (1) WO1992014734A1 (enExample)
YU (1) YU48238B (enExample)
ZA (1) ZA921005B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2235725C2 (ru) * 1998-04-29 2004-09-10 Астразенека Аб Производные имидазопиридина, способ их получения и промежуточные соединения, фармацевтический препарат на их основе (варианты), способ ингибирования секреции желудочной кислоты и способ лечения состояний, в которые вовлечено инфицирование h.pylori

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
EP0775139A1 (en) * 1994-08-10 1997-05-28 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
BR9609892A (pt) * 1995-08-05 1999-05-25 British Biotech Pharm Derivados de imidazopiridina
PT1311269E (pt) 2000-08-04 2012-05-10 Dmi Biosciences Inc Método de utilização de dicetopiperazinas e composição que contém as mesmas
ES2575563T3 (es) 2003-05-15 2016-06-29 Ampio Pharmaceuticals, Inc. Tratamiento de enfermedades mediadas por los linfocitos T
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
BRPI0821909A2 (pt) 2008-01-30 2018-07-17 Nippon Zoki Pharmaceutical Co., Ltd. derivado de piperidina
EP2300011A4 (en) 2008-05-27 2012-06-20 Dmi Life Sciences Inc THERAPEUTIC PROCESSES AND COMPOUNDS
JP5978296B2 (ja) * 2011-06-28 2016-08-24 フジアン・ミンドン・レジュヴネイション・ファーマスーティカル・カンパニー・リミテッド 抗アレルギ性ベンゾシクロヘプタチオフェン誘導体
SG10201608087WA (en) 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
SG10201608103YA (en) 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Treatment of degenerative joint disease
CA2846394A1 (en) * 2011-10-28 2013-05-02 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
WO2014145729A2 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
EP3183240A4 (en) 2014-08-18 2018-06-27 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
HK1246669A1 (zh) 2015-06-22 2018-09-14 Ampio Pharmaceuticals, Inc. 人血清白蛋白低分子量组分在疾病治疗中的应用
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3326924A (en) * 1963-04-24 1967-06-20 Schering Corp Novel aza-dibenzo[a, d]-cycloheptene derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989008653A1 (en) * 1988-03-15 1989-09-21 G.D. Searle & Co. 1H/3H-[4-(N,N-DICYCLOALKYL/BRANCHED-ALKYLCARBOXAMIDO)-BENZYL]IMIDAZO[4,5-c]PYRIDINES AS PAF ANTAGONISTS
NZ228889A (en) * 1988-04-28 1991-09-25 Schering Corp Fused tri- or tetracyclic heterocyclic compounds and pharmaceutical compositions
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
AU642265B2 (en) * 1990-05-09 1993-10-14 Pfizer Inc. Imidazo (4,5-c) pyridines with PAF antagonist activity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3326924A (en) * 1963-04-24 1967-06-20 Schering Corp Novel aza-dibenzo[a, d]-cycloheptene derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2235725C2 (ru) * 1998-04-29 2004-09-10 Астразенека Аб Производные имидазопиридина, способ их получения и промежуточные соединения, фармацевтический препарат на их основе (варианты), способ ингибирования секреции желудочной кислоты и способ лечения состояний, в которые вовлечено инфицирование h.pylori
RU2238271C2 (ru) * 1998-04-29 2004-10-20 Астразенека Аб Производные имидазопиридина, способы их получения и промежуточные соединения, фармацевтический препарат на их основе (варианты), способ ингибирования секреции желудочной кислоты, способ лечения желудочно-кишечных воспалительных заболеваний и способ лечения состояний, в которых вовлечено инфицирование h.pylori

Also Published As

Publication number Publication date
IL100887A (en) 1996-01-19
ES2059212T3 (es) 1994-11-01
AU1168392A (en) 1992-09-15
FI933531A0 (fi) 1993-08-10
NO932889L (no) 1993-08-13
YU48238B (sh) 1997-08-22
IL100887A0 (en) 1992-11-15
CA2099381A1 (en) 1992-08-14
BR9205615A (pt) 1994-05-17
PL169304B1 (pl) 1996-06-28
CA2099381C (en) 1996-07-09
FI933531L (fi) 1993-08-10
WO1992014734A1 (en) 1992-09-03
ATE109482T1 (de) 1994-08-15
AU650322B2 (en) 1994-06-16
TW227000B (enExample) 1994-07-21
CS42592A3 (en) 1992-09-16
JP2506541B2 (ja) 1996-06-12
HU9302327D0 (en) 1993-10-28
GB9102997D0 (en) 1991-03-27
FI933531A7 (fi) 1993-08-10
DE69200304T2 (de) 1994-12-08
DK0572425T3 (da) 1994-09-12
ZA921005B (en) 1993-08-12
HU211202A9 (en) 1995-11-28
IE65125B1 (en) 1995-10-04
NZ241597A (en) 1993-04-28
EP0572425A1 (en) 1993-12-08
NO300592B1 (no) 1997-06-23
MY108437A (en) 1996-09-30
CN1064275A (zh) 1992-09-09
DE69200304D1 (de) 1994-09-08
EP0572425B1 (en) 1994-08-03
US5358953A (en) 1994-10-25
IE920449A1 (en) 1992-08-12
JPH06504992A (ja) 1994-06-09
CN1040326C (zh) 1998-10-21
HUT65947A (en) 1994-08-29
EG20085A (en) 1997-05-31
CZ280504B6 (cs) 1996-02-14
KR970005302B1 (ko) 1997-04-15
YU14392A (sh) 1994-11-15
NO932889D0 (no) 1993-08-13
MX9200589A (es) 1992-10-01

Similar Documents

Publication Publication Date Title
RU2114845C1 (ru) Производные имидазопиридина или их фармацевтически приемлемые соли, способ их получения и фармацевтическая композиция, проявляющая антагонистическую активность в отношении гистамина (h1)
JP4216197B2 (ja) 新規ピリジン及びキノリン誘導体
CA2494700C (en) Calcium receptor modulating compound and use thereof
KR900007780B1 (ko) 축합된 피롤리논 유도체의 제조방법
US5250531A (en) Dihydropyrimidine antiallergy agents
CZ302792A3 (en) Intima atherosclerotic concretion inhibitor
PT87604B (pt) Processo para a preparacao de agentes anti-alergicos e anti-inflamatorios di-hidropiridinicos
US4192944A (en) Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents
IE903616A1 (en) Neuroprotectant Agents
CN110698411B (zh) 一类4-(胺烷基)酞嗪-1-酮类化合物、其制备方法和用途
GB2233974A (en) Dihydropyridine antiinflammatory agent
EP0462986B1 (en) Imidazopyrimidine antiallergy agents
FI101225B (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-metyyli-imidatso£4,5-c|py rid-1-yylijohdannaisten valmistamiseksi
JPH05507932A (ja) イミダゾピリジンｐａｆ拮抗薬
IE913102A1 (en) Therapeutic agents
CN1950370B (zh) 对映体纯的六氢吡咯并环戊吡啶-衍生物
CA2101933A1 (en) Neuroprotectant agents
PT100223B (pt) Processo para a preparacao de imidazopiridinas antagonistas de paf/h1
MXPA98002238A (en) Derivatives of acriloilguanidina substituted with heteroarilos and medicinal composition of mis